Reporting of test results. A landlord or a person registered with the Department of Health and Human Services pursuant to Title 22, chapter 165 who has conducted a test of a residential building as required by this section or accepted the results of a tenant-initiated test as set forth in subsection 6 shall report the results of the test to the Department of Health and Human Services within 30 days of receipt of the results in a form and manner required by the department. [PL 2013, c. 324, §2 (NEW).]
Reporting of test results. Once samples have arrived at the laboratory via approved carrier, CONTRACTOR shall provide a reporting of test results to Probation within 48-72 hours. CONTRACTOR shall make such reporting through an electronic file format, as described in Section III.I (“Electronic Reporting of Test Results”) of this CONTRACT. All test results must be stored and maintained by the CONTRACTOR, and made available to Probation upon request.”
Reporting of test results. Reporting of test results conducted via telephone, email, or the Platform to Customer’s designated program manager and/or selected authorized contacts for all drug test results. Test results are also made available to authorized users in the Xxxxx Platform.
Reporting of test results. A. The Collection Site shall report test results to the Drug Testing Coordinator within an average of five (5) working days after the receipt of the specimen by the laboratory. Before reporting any test results to the Department, the Collection Site’s Medical Review Officer (MRO) shall review and certify accurate all test results. The results (both positive and negative) for all specimens submitted at the same time to the laboratory shall be reported back to the Drug Testing Coordinator at the same time. The test result report shall include but is not limited to the following:
1. Identification of the drugs/metabolites tested for
2. Test results, positive or negative
3. The cut-off level for each drug tested for
4. Chain of Custody number assigned
B. In instances where the Collection Site determines that a member’s breath alcohol (BrAC) test results are in excess of proscribed levels, the site’s responsible person shall review and certify accurate all test results. The Collection Site shall subsequently and immediately report the results to the Drug Testing Coordinator and not release the Department member from the Collection Site. This is to ensure that the member not operate a Department vehicle and place himself/herself or members of the public in jeopardy. The Drug Testing Coordinator or member’s supervisor shall arrange transportation of the member back to the Department.
C. All members shall be notified, in writing, of the results of their drug/alcohol screening test, whether positive or negative. The notification shall identify the particular drug(s) or controlled substance(s) or their metabolites and shall specify the concentration level. The notification shall include any breath alcohol test results. Breath alcohol results may also be given verbally to the member at the time of testing.
Reporting of test results. After completing the test measurements, the Laboratory is to prepare a report on the measurement results, describing the tests performed, the measurement methods used, the measuring conditions and other relevant conditions applying to the measurements. As a minimum the report should include the following: • For each product, a clear and concise report is to be prepared which contains the performance data and results of the test measurements. The report must state clearly whether the tested product sample and the model comply with the requirements or whether the sample is in non-compliance with the requirements (i.e. whether the sample failed the test). If the test measurement is for checking an energy label, the report must state to which energy class the value or values measured belongs. Both the permitted and the measured deviations are to be stated in the report, and the model's deviations from the requirements must be identified clearly and without ambiguity. The report is to include a short section with details of the test conclusions written in a clear and concise (non-technical) manner. An overview report for the complete series of measurements (all the models covered by the measurements), stating how many of the samples tested complied with the requirements. The overview report must also contain any other relevant observations made by the Laboratory in connection with the series of measurements. These may relate to the reasons for non-compliance with the regulations (especially if there are general trends), including problems with carrying out the tests, problems with the measurement standards, or similar issues. • A brief summary. The summary should be separate from the above-mentioned report, as it will be used in the dialogue with the product suppliers. All reports and summaries should be in English. Separate reports must be prepared, both following the testing of one product sample, and after the follow- up testing of additional product samples. After completion of a series of measurements of at least five product samples (for lighting, see sub- agreement 5 (5 batches x 20 units)) and delivery of the documents referred to above, upon request and at no cost to the Customer, the Laboratory must take part in a one-hour telephone conference with the Customer to clarify the results of the report and answer any questions.
Reporting of test results. All QC test reports shall be submitted as soon as practical, but no later than the day following the test. Test data shall be immediately provided to the engineer upon request at any time, including prior to the submission of the test report. No payment will be made for the work performed until acceptable QC test results have been received by the engineer and confirmed by QA test results.
Reporting of test results. The laboratory shall report test results to the MRO. All test results shall be certified as accurate by the responsible person at the laboratory. Results should not be transmitted by telephone, and transmission by other electronic means (computer, teleprinter or facsimile) shall be permissible. All specimens which test negative on the initial test or negative on the confirmatory test shall be reported as negative. Only specimens confirmed positive shall be reported positive for a specific drug or drugs.
